Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: The paradox of beneficial treatment effects in nonresponders in the ATTRACT trial
- 1 November 2001
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (11) , 2703-2704
- https://doi.org/10.1002/1529-0131(200111)44:11<2703::aid-art451>3.0.co;2-e
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritisArthritis & Rheumatism, 2000
- Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritisThe Lancet, 1997
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.Annals of the Rheumatic Diseases, 1990
- EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITISThe Lancet, 1989